PMON169 D2R Expression in Dopamine-Agonist Resistant Prolactinomas
Author(s) -
Alice C. Levine,
Ilana R Bass,
Eva de Alba,
Melissa Umphlett,
William P. Shuman,
Emily Milgrim,
Lucas Milgrim,
Joshua B. Bederson,
Kalmon D. Post,
Raj Shrivastava
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1139
Subject(s) - cabergoline , prolactinoma , dopamine agonist , tmprss2 , prolactin cell , prolactin , agonist , medicine , endocrinology , cancer research , dopamine receptor d2 , prostate cancer , biology , oncology , cancer , dopamine , receptor , hormone , disease , covid-19 , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom